HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Microglia plays a crucial role in the pathogenesis of HIV-1-associated neurocognitive disorders. Increasing evidence indicates the voltage-gated potassium (Kv) channels are involved in the regulation of microglia function, prompting us to hypothesize Kv channels may also be involved in microglia-mediated neurotoxic activity in HIV-1-infected brain. To test this hypothesis, we investigated the involvement of Kv channels in the response of microglia to HIV-1 Tat protein. Treatment of rat microglia with HIV-1 Tat protein (200 ng/ml) resulted in pro-inflammatory microglial activation, as indicated by increases in TNF-α, IL-1β, reactive oxygen species, and nitric oxide, which were accompanied by enhanced outward K(+) current and Kv1.3 channel expression. Suppression of microglial Kv1.3 channel activity, either with Kv1.3 channel blockers Margatoxin, 5-(4-Phenoxybutoxy)psoralen, or broad-spectrum K(+) channel blocker 4-Aminopyridine, or by knockdown of Kv1.3 expression via transfection of microglia with Kv1.3 siRNA, was found to abrogate the neurotoxic activity of microglia resulting from HIV-1 Tat exposure. Furthermore, HIV-1 Tat-induced neuronal apoptosis was attenuated with the application of supernatant collected from K(+) channel blocker-treated microglia. Lastly, the intracellular signaling pathways associated with Kv1.3 were investigated and enhancement of microglial Kv1.3 was found to correspond with an increase in Erk1/2 mitogen-activated protein kinase activation. These data suggest targeting microglial Kv1.3 channels may be a potential new avenue of therapy for inflammation-mediated neurological disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Heaton, R. K., Clifford, D. B., Franklin, D. R., Woods, S. P., Ake, C., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J. H., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e318200d727 · Cited by 2,353
Microglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645
Nagata, Y., & Todokoro, K. (1999) · Blood · doi:10.1182/blood.v94.3.853.415a12_853_863 · Cited by 218 · cited 1×
“neuronal damage [22,44,45,46] in a process mediated through”
BackgroundMicroglia Kv1.3 Channels Contribute to Their Ability to Kill Neurons
Fordyce, C. B., Jagasia, R., Zhu, X., & Schlichter, L. C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1251-05.2005 · Cited by 213 · cited 2×
“3 expression inhibits microglia-induced neurotoxicity [22,23].”
BackgroundSchilling, T., & Eder, C. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22675 · Cited by 117
Beeton, C., Wulff, H., Singh, S., Botsko, S., Crossley, G., Gutman, G. A., Cahalan, M. D., Pennington, M., & Chandy, K. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212868200 · Cited by 90
Liu, J., Xu, C., Chen, L., Xu, P., & Xiong, H. (2012) · Cell Death & Disease · doi:10.1038/cddis.2011.140 · Cited by 47
Self-citation
Research works printed but not linked: 53
- M Kaul, 2006, Mechanisms of neuronal injury and death in HIV-1 associated dementia, Curr HIV Res, 4, 307, 10.2174/157016206777709384 · DOI · Paper page
- KR Robertson, 2007, The prevalence and incidence of neurocognitive impairment in the HAART era, AIDS, 21, 1915, 10.1097/QAD.0b013e32828e4e27 · DOI · Paper page
- SS Spudich, 2011, Central nervous system complications of HIV infection, Top Antivir Med, 19, 48
- JD Glass, 1995, Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia, Ann Neurol, 38, 755, 10.1002/ana.410380510 · DOI · Paper page
- Gendelman HE, Eiden L, Epstein L, Grant I, Lipton S, <etal>et al</etal>.. (1998) The Neuropathogenesis of HIV-1-Dementia: APanel Discussion. In: Gendelman HE, Lipton SA, Epstein LG, Swindells S, editors. The neurology of AIDS. 1 ed. New York: Chapman and Hall. pp. 1–10.
- GA Garden, 2002, Microglia in human immunodeficiency virus-associated neurodegeneration, Glia, 40, 240, 10.1002/glia.10155 · DOI · Paper page
- T Kielian, 2004, Microglia and chemokines in infectious diseases of the nervous system: views and reviews, Front Biosci, 9, 732, 10.2741/1266 · DOI
- H Kettenmann, 2011, Physiology of microglia, Physiol Rev, 91, 461, 10.1152/physrev.00011.2010 · DOI · Paper page
- A Wickenden, 2002, K(+) channels as therapeutic drug targets, Pharmacol Ther, 94, 157, 10.1016/S0163-7258(02)00201-2 · DOI · Paper page
- SI Judge, 2006, Voltage-gated potassium channels in multiple sclerosis: Overview and new implications for treatment of central nervous system inflammation and degeneration, J Rehabil Res Dev, 43, 111, 10.1682/JRRD.2004.09.0116 · DOI
- W Norenberg, 1994, Voltage-dependent potassium channels in activated rat microglia, J Physiol, 475, 15, 10.1113/jphysiol.1994.sp020046 · DOI · Paper page
- HG Fischer, 1995, Cytokine-dependent K+ channel profile of microglia at immunologically defined functional states, Neuroscience, 64, 183, 10.1016/0306-4522(94)00398-O · DOI
- C Eder, 1998, Ion channels in microglia (brain macrophages), Am J Physiol, 275, C327, 10.1152/ajpcell.1998.275.2.C327 · DOI · Paper page
- T Schilling, 2000, Upregulation of Kv1.3 K(+) channels in microglia deactivated by TGF-beta, Am J Physiol Cell Physiol, 279, C1123, 10.1152/ajpcell.2000.279.4.C1123 · DOI · Paper page
- H Kettenmann, 1990, Cultured microglial cells have a distinct pattern of membrane channels different from peritoneal macrophages, J Neurosci Res, 26, 278, 10.1002/jnr.490260303 · DOI · Paper page
- C Eder, 1999, Morphological, immunophenotypical and electrophysiological properties of resting microglia in vitro, Eur J Neurosci, 11, 4251, 10.1046/j.1460-9568.1999.00852.x · DOI · Paper page
- W Walz, 2001, Ion channels in cultured microglia, Microsc Res Tech, 54, 26, 10.1002/jemt.1117 · DOI
- K Farber, 2005, Physiology of microglial cells, Brain Res Brain Res Rev, 48, 133, 10.1016/j.brainresrev.2004.12.003 · DOI · Paper page
- HE Gendelman, 2009, Monocyte chemotactic protein-1 regulates voltage-gated K+ channels and macrophage transmigration, J Neuroimmune Pharmacol, 4, 47, 10.1007/s11481-008-9135-1 · DOI · Paper page
- N Nutile-McMenemy, 2007, Minocycline decreases in vitro microglial motility, beta1-integrin, and Kv1.3 channel expression, J Neurochem, 103, 2035, 10.1111/j.1471-4159.2007.04889.x · DOI · Paper page
- C Xu, 2011, HIV-1 gp120 enhances outward potassium current via CXCR4 and cAMP-dependent protein kinase A signaling in cultured rat microglia, Glia, 59, 997, 10.1002/glia.21171 · DOI
- MO Westendorp, 1995, Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120, Nature, 375, 497, 10.1038/375497a0 · DOI · Paper page
- H Xiao, 2000, Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1, Proc Natl Acad Sci U S A, 97, 11466, 10.1073/pnas.97.21.11466 · DOI · Paper page
- R Bonavia, 2001, HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons, Biochem Biophys Res Commun, 288, 301, 10.1006/bbrc.2001.5743 · DOI
- K Hayashi, 2006, HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier, J Cereb Blood Flow Metab, 26, 1052, 10.1038/sj.jcbfm.9600254 · DOI
- M Koistinaho, 2002, Role of p38 and p44/42 mitogen-activated protein kinases in microglia, Glia, 40, 175, 10.1002/glia.10151 · DOI · Paper page
- M Strniskova, 2002, Mitogen-activated protein kinases and their role in regulation of cellular processes, Gen Physiol Biophys, 21, 231
- B Kaminska, 2009, MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target, Anat Rec (Hoboken), 292, 1902, 10.1002/ar.21047 · DOI · Paper page
- S Koenig, 1986, Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy, Science, 233, 1089, 10.1126/science.3016903 · DOI · Paper page
- P Genis, 1992, Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease, J Exp Med, 176, 1703, 10.1084/jem.176.6.1703 · DOI · Paper page
- M Kaul, 2001, Pathways to neuronal injury and apoptosis in HIV-associated dementia, Nature, 410, 988, 10.1038/35073667 · DOI · Paper page
- A Menteyne, 2009, Predominant functional expression of Kv1.3 by activated microglia of the hippocampus after Status epilepticus, PLoS One, 4, e6770, 10.1371/journal.pone.0006770 · DOI · Paper page
- AA Alizadeh, 2000, Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling, Nature, 403, 503, 10.1038/35000501 · DOI · Paper page
- M Abdul, 2003, Activity of potassium channel-blockers in breast cancer, Anticancer Res, 23, 3347
- M Brevet, 2008, Expression of K+ channels in normal and cancerous human breast, Histol Histopathol, 23, 965
- S Kramer-Hammerle, 2005, Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus, Virus Res, 111, 194, 10.1016/j.virusres.2005.04.009 · DOI · Paper page
- SU Kim, 2005, Microglia in health and disease, J Neurosci Res, 81, 302, 10.1002/jnr.20562 · DOI · Paper page
- ST Dheen, 2007, Microglial activation and its implications in the brain diseases, Curr Med Chem, 14, 1189, 10.2174/092986707780597961 · DOI · Paper page
- YB Lee, 2000, p38 map kinase regulates TNF-alpha production in human astrocytes and microglia by multiple mechanisms, Cytokine, 12, 874, 10.1006/cyto.2000.0688 · DOI
- JR Lokensgard, 2001, Diazepam inhibits HIV-1 Tat-induced migration of human microglia, J Neurovirol, 7, 481, 10.1080/135502801753170345 · DOI
- EA Eugenin, 2005, HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS, Glia, 49, 501, 10.1002/glia.20137 · DOI · Paper page
- S Visentin, 2001, Altered outward-rectifying K(+) current reveals microglial activation induced by HIV-1 Tat protein, Glia, 33, 181, 10.1002/1098-1136(200103)33:3<181::AID-GLIA1017>3.0.CO;2-Q · DOI
- JP Keblesh, 2009, 4-Aminopyridine improves spatial memory in a murine model of HIV-1 encephalitis, J Neuroimmune Pharmacol, 4, 317, 10.1007/s11481-009-9161-7 · DOI
- KG Chandy, 2004, K+ channels as targets for specific immunomodulation, Trends Pharmacol Sci, 25, 280, 10.1016/j.tips.2004.03.010 · DOI · Paper page
- C Beeton, 2006, Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases, Proc Natl Acad Sci U S A, 103, 17414, 10.1073/pnas.0605136103 · DOI · Paper page
- KG Chandy, 1984, Voltage-gated potassium channels are required for human T lymphocyte activation, J Exp Med, 160, 369, 10.1084/jem.160.2.369 · DOI · Paper page
- H Wulff, 2003, Potassium channels as therapeutic targets for autoimmune disorders, Curr Opin Drug Discov Devel, 6, 640
- H Wulff, 2003, The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS, J Clin Invest, 111, 1703, 10.1172/JCI16921 · DOI · Paper page
- R Vianna-Jorge, 2004, Potassium channels in T lymphocytes: therapeutic targets for autoimmune disorders?, BioDrugs, 18, 329, 10.2165/00063030-200418050-00005 · DOI
- C Beeton, 2011, Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases, Inflamm Allergy Drug Targets, 10, 313, 10.2174/187152811797200641 · DOI
- P Valverde, 2005, Potassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal disease, J Dent Res, 84, 488, 10.1177/154405910508400603 · DOI
- B Goffe, 2005, An integrated analysis of thirteen trials summarizing the long-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy, Clin Ther, 27, 1912, 10.1016/j.clinthera.2005.12.007 · DOI
- F Esamai, 2005, A randomized open label clinical trial to compare the efficacy and safety of intravenous quinine followed by oral malarone vs. intravenous quinine followed by oral quinine in the treatment of severe malaria, J Trop Pediatr, 51, 17, 10.1093/tropej/fmh069 · DOI
Cited by
The Prevalence of Inappropriate Image Duplication in Biomedical Research Publications
Bik, E. M., Casadevall, A., & Fang, F. C. (2016) · mBio · doi:10.1128/mbio.00809-16 · Cited by 287
Potassium Channel Kv1.3 Is Highly Expressed by Microglia in Human Alzheimer's Disease
Rangaraju, S., Gearing, M., Jin, L.-W., & Levey, A. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141704 · Cited by 137
Blockade of Kv1.3 channels ameliorates radiation-induced brain injury
Peng, Y., Lu, K., Li, Z., Zhao, Y., Wang, Y., Hu, B., Xu, P., Shi, X., Zhou, B., Pennington, M., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not221 · Cited by 78
Self-citationRangaraju, S., Raza, S. A., Pennati, A., Deng, Q., Dammer, E. B., Duong, D., Pennington, M. W., Tansey, M. G., Lah, J. J., Betarbet, R., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0906-6 · Cited by 75
“3 channel co-localization may also be highly relevant to neuroinfectious, neuroinflammatory, and neurodegenerative disorders, where TLR activation has pathologic relevance [55, 56].”
Background
Metadata
- Authors
- Liu, J., Xu, P., Collins, C., Liu, H., Zhang, J., Keblesh, J. P., & Xiong, H.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-05-30
- Volume
- 8
- Issue
- 5
- Pages
- e64904
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1967851503
- Cited by
- 28
- References
- 8
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-09-19)
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity. https://app.cochat.ai/papers/10.1371/journal.pone.0064904
- The paper
- Liu, J., Xu, P., Collins, C., Liu, H., Zhang, J., Keblesh, J. P., & Xiong, H. (2013). HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity. PLoS ONE. https://doi.org/10.1371/journal.pone.0064904
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.